Quest Diagnostics Offers New Liquid Biopsy Lung Cancer Test
Biocept’s liquid biopsy-based Target Selector NGS Lung Panel test aids genomic profiling in patients with advanced non-small cell lung cancer (NSCLC).
Read MorePosted by Andy Lundin | Dec 6, 2021 | Lung Cancer |
Biocept’s liquid biopsy-based Target Selector NGS Lung Panel test aids genomic profiling in patients with advanced non-small cell lung cancer (NSCLC).
Read MorePosted by Chris Wolski | Nov 12, 2021 | Lung Cancer |
An engineering professor has received a $2.4M grant for a faster, less painful way to diagnose malignant solitary pulmonary nodules.
Read MorePosted by Chris Wolski | Nov 12, 2021 | Molecular Diagnostic Analyzers, Respiratory Disease |
Asuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MorePosted by Chris Wolski | Oct 28, 2021 | Middleware & Software |
The latest version of Tribun Health’s CaloPix 5 is an AI-powered computational pathology solution for diagnostics, prognosis, and drug development.
Read MorePosted by Chris Wolski | Oct 21, 2021 | Lung Cancer |
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read More